143 related articles for article (PubMed ID: 11168850)
1. Reduced expression of CD9 in oral squamous cell carcinoma: CD9 expression inversely related to high prevalence of lymph node metastasis.
Kusukawa J; Ryu F; Kameyama T; Mekada E
J Oral Pathol Med; 2001 Feb; 30(2):73-9. PubMed ID: 11168850
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma.
Buim ME; Lourenço SV; Carvalho KC; Cardim R; Pereira C; Carvalho AL; Fregnani JH; Soares FA
Oral Oncol; 2010 Mar; 46(3):166-71. PubMed ID: 20060356
[TBL] [Abstract][Full Text] [Related]
3. Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma.
Hirano C; Nagata M; Noman AA; Kitamura N; Ohnishi M; Ohyama T; Kobayashi T; Suzuki K; Yoshizawa M; Izumi N; Fujita H; Takagi R
Int J Cancer; 2009 Jun; 124(12):2911-6. PubMed ID: 19330835
[TBL] [Abstract][Full Text] [Related]
4. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
5. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
7. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer.
Miyake M; Nakano K; Itoi SI; Koh T; Taki T
Cancer Res; 1996 Mar; 56(6):1244-9. PubMed ID: 8640807
[TBL] [Abstract][Full Text] [Related]
8. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity.
Kusukawa J; Sasaguri Y; Morimatsu M; Kameyama T
J Oral Maxillofac Surg; 1995 May; 53(5):530-4. PubMed ID: 7722722
[TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
[TBL] [Abstract][Full Text] [Related]
11. Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential.
Crowe DL; Milo GE; Shuler CF
J Dent Res; 1999 Jun; 78(6):1256-63. PubMed ID: 10371250
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand expression in esophageal carcinomas and their lymph node metastases.
Younes M; Schwartz MR; Ertan A; Finnie D; Younes A
Cancer; 2000 Feb; 88(3):524-8. PubMed ID: 10649242
[TBL] [Abstract][Full Text] [Related]
13. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma.
Nagata M; Noman AA; Suzuki K; Kurita H; Ohnishi M; Ohyama T; Kitamura N; Kobayashi T; Uematsu K; Takahashi K; Kodama N; Kawase T; Hoshina H; Ikeda N; Shingaki S; Takagi R
BMC Cancer; 2013 Sep; 13():410. PubMed ID: 24006899
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis.
Ohba S; Fujii H; Ito S; Fujimaki M; Matsumoto F; Furukawa M; Yokoyama J; Kusunoki T; Ikeda K; Hino O
J Oral Pathol Med; 2010 Jan; 39(1):74-8. PubMed ID: 19709351
[TBL] [Abstract][Full Text] [Related]
15. Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck.
Mhawech P; Dulguerov P; Tschanz E; Verdan C; Ares C; Allal AS
Br J Cancer; 2004 Jan; 90(2):471-5. PubMed ID: 14735195
[TBL] [Abstract][Full Text] [Related]
16. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis.
Kunishi M; Kayada Y; Yoshiga K
Int J Oral Maxillofac Surg; 1997 Aug; 26(4):280-3. PubMed ID: 9258720
[TBL] [Abstract][Full Text] [Related]
17. Immune response in cervical lymph nodes from patients with primary oral squamous cell carcinoma.
Gonçalves AS; Costa NL; Arantes DA; de Cássia Gonçalves Alencar R; Silva TA; Batista AC
J Oral Pathol Med; 2013 Aug; 42(7):535-40. PubMed ID: 23278174
[TBL] [Abstract][Full Text] [Related]
18. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
19. Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma.
Marioni G; Marino F; Giacomelli L; Staffieri C; Mariuzzi ML; Violino E; De Filippis C
Acta Otolaryngol; 2006 Jun; 126(6):633-9. PubMed ID: 16720449
[TBL] [Abstract][Full Text] [Related]
20. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M
Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
